HemostOD secures CHF 4.3 million seed extension to advance through pre-IND development and commercial scale production Lausanne, Switzerland — 1st October 2025 – HemostOD, a private Swiss company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback